相关实验视频
Updated: Jun 11, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
在法洛特四分法中的BT分流的作用
Faiz Rasool1, Amna Zafer Qureshi1, Asim Khan2
1Children Hospital Lahore, Lahore, Punjab, Pakistan.
Cardiology in the young
|October 10, 2024
概括
修改后的布拉洛克 - 陶西格 (BT) 顺差在法洛特 (TOF) 患者的四重症中使用量正在下降. 像PDA/RVOT支架这样的替代程序正在变得越来越普遍,这表明BT支架可能很快就会过时.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 生产性心脏病 手术 手术 生产性心脏病
背景情况:
- 修改后的Blalock-Taussig (BT) 突变是一种缓解性手术程序,用于肺血流减少的蓝色心脏病.
- 虽然历史上用于法洛特四分法 (TOF),但其在现代实践中的应用正在减少.
研究的目的:
- 为了评估在一个研究所对TOF的BT分流的5年经验.
- 评估用于TOF管理的BT道的使用趋势.
主要方法:
- 一项回顾性研究分析了2019年1月至2023年12月的患者数据.
- 关键数据点包括患者人口统计,手术结果和手术指示.
主要成果:
- 173名患者在2019年至2023年期间接受了对TOF的BT分流.
- 主要的征兆是医疗耐药的超性咒语,通常在紧急情况下.
- 在BT分流后的整体死亡率为15%.
结论:
- 对TOF的BT分流的使用正在减少,主要是由于替代息技术的进步,如PDA/RVOT支架.
- 在未来,BT分流可能会成为TOF管理的过时,即使是在发展中国家.
更多相关视频
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
16.7K
09:31Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
864
相关概念视频
Mitral Stenosis I: Introduction
2
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1